Invitation to a conference call and webcast in connection with Isofol receiving recommendation to complete the global Phase III AGENT study for market registration as planned with 440 patients ...Middle East

GOTHENBURG, Sweden, March 22, 2021 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) announced on 19 March 2021 that the independent Data Safety and Monitoring Board (iDSMB) has recommended continuation of the global Phase III AGENT...

Hence then, the article about invitation to a conference call and webcast in connection with isofol receiving recommendation to complete the global phase iii agent study for market registration as planned with 440 patients was published today ( Monday 22/03/2021 - 11:47 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Invitation to a conference call and webcast in connection with Isofol receiving recommendation to complete the global Phase III AGENT study for market registration as planned with 440 patients )

Also on site :

• Starbucks’ New ChatGPT Integration Is a Potential Privacy Nightmare
• What You Can Expect to Pay to Get Into Fitness
• Trader Joe's $4 Find Has Returned — Why Fans Obsess Over the Easy Dinner